Results 181 to 190 of about 358,809 (243)

Exploring the Associations Between Affective and Non‐Affective Cognitive Domains in Mood Disorders and Healthy Controls Using Network Analysis

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Cognitive impairment is a core feature of mood disorders that contributes to reduced functioning and poorer prognosis, thereby emerging as an important treatment target. Persistent trait‐related impairments present within both affective and non‐affective cognition. Nevertheless, the relationship between affective and non‐affective
Hanne Lie Kjærstad   +5 more
wiley   +1 more source

HIV expression persists in the cerebrospinal fluid of HIV-associated neurocognitive disorders despite effective ART. [PDF]

open access: yesEmerg Microbes Infect
Prates GS   +15 more
europepmc   +1 more source

Acute‐Phase Interventions After Self‐Harm for Preventing Suicide and Recurrence: A Systematic Review and Meta‐Analysis

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Suicide risk is markedly elevated following presentation after self‐harm, yet the evidence base for interventions initiated in the immediate post‐presentation period has not been synthesized with specific attention to this high‐risk window. Clarifying which early interventions may reduce adverse outcomes is essential for informing
Guilherme Pimenta Roncete   +7 more
wiley   +1 more source

A revised neuropsychological test battery, CoCoBattery-Plus, for the diagnosis of HIV-associated neurocognitive disorders in Japan. [PDF]

open access: yesAIDS Res Ther
Nakao A   +9 more
europepmc   +1 more source

Detecting cannabis use reduction through biochemical verification of urinary cannabinoids: An aggregated analysis of cannabis use disorder treatment trials examining average reductions and individual cut‐points

open access: yesAddiction, EarlyView.
Abstract Background and aims Currently, there is no data‐driven cannabis reduction metric using biochemical verification, which represents a significant gap in cannabis harm reduction research, treatment and policy. Using aggregated data from 7 cannabis use disorder treatment trials, the aims of this analysis were to 1) determine if decreases in self ...
Erin A. McClure   +6 more
wiley   +1 more source

The association of methadone use with physical function and frailty among persons who inject drugs

open access: yesAddiction, EarlyView.
Abstract Background and Aims Persons who inject drugs (PWID) experience a high burden of early‐onset frailty, primarily due to multifactorial causes such as infections (human immunodeficiency virus [HIV], hepatitis C virus [HCV]), substance use, and polypharmacy.
Grace L. Kulik   +10 more
wiley   +1 more source

Hippocampal subfield differences in people with and without recreational ketamine use: Insights from multi‐modal neuroimaging

open access: yesAddiction, EarlyView.
Abstract Background and aims Recreational ketamine use has increased globally and is associated with psychiatric and cognitive concerns. The hippocampus in preclinical models shows damage and working‐memory disruption with repeated dosing. However, whether specific hippocampal subregions may differ in people with chronic ketamine use remains unclear ...
Yi‐Hsuan Liu   +8 more
wiley   +1 more source

Elevated sCD14 in cerebrospinal fluid: a surrogate marker for HIV-associated neurocognitive disorders in Brazil. [PDF]

open access: yesAIDS
Apoliano CF   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy